1. Counsel Presented On Merck Serono's Cilengitide Block Current Clinical Check In NSCLC Accordance to query: 100%
   Fragments of message : ... Counsel Presented On Merck Serono's Cilengitide Block Current Clinical Check In NSCLC The interpret investigated the efficacy and safety of three Potion regimens of cilengitide versus docetaxel... ... The Page II comparative results propose that, after also proof, cilengitide may admit an crucial role in the treatment of NSCLC," said the Principal Investigator of the peruse, Professor Christian Manegold from the Heidelberg University Medical Centre, Mannheim, Germany... ... We are model eager approximately the latent of our overdue-sheet pipeline products, cilengitide and Stimuvax," said Dr Wolfgang Wein, Executive Vise Head of the state, Oncology, Merck Serono... ... Manegold C, et al... More: http://pharmacies-information.com/post_1250235911.html
   

   ---

   
   

History of SE queries